Posted on 5/1/18
Eloxx Pharmaceuticals Announces Completion of Public Offering of Common Stock
WALTHAM, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq:ELOX) today announced the completion of its previously announced underwritten public offering of 5,899,500 . . .
Posted on 5/1/18
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine . . .
Posted on 5/1/18
Keryx Biopharmaceuticals Announces Changes to Management
BOSTON, April 30, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced . . .
Posted on 4/30/18
athenahealth's (ATHN) CEO Jonathan Bush on Q1 2018 Results - Earnings Call Transcript
athenahealth, Inc. (NASDAQ:ATHN) Q1 2018 Results Earnings Conference Call April 26, 2018 8:00 AM ETExecutivesDana Quattrochi - IRJonathan Bush - CEOMarc Levine - CFOAnalystsMohan Naidu - . . .
Posted on 4/30/18
Athenahealth, Inc. First-Quarter Earnings Soar As Cost-Cutting Pays Off
Investors had one primary question for athenahealth, Inc. (NASDAQ:ATHN) prior to the company's first-quarter earnings report: Can the momentum continue? Athenahealth ended 2017 on a positive . . .
Posted on 4/30/18
Is Bristol-Myers Squibb Stock a Buy After Its Mixed Q1 Results?
Wall Street didn't like what Bristol-Myers Squibb (NYSE:BMY) had to say on Thursday -- at least not all of it -- when the big drugmaker reported . . .
Posted on 4/30/18
Is Biogen Inc. a Buy?
Biotech heavyweight Biogen (NASDAQ:BIIB) has now lost over 13% of its value so far this year. To be fair, this year hasn't been kind to biotechs . . .
Posted on 4/29/18
Lyndra and Global Drug Commercialization Center Announce Joint Venture
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Inc., an emerging biopharmaceutical company, today announced the formation of a joint venture with Global Drug Commercialization Center (GDCC) to commercialize Lyndra’s groundbreaking . . .
Posted on 4/29/18
Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone
LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has surpassed an . . .
Posted on 4/27/18
Advantagene Announces Clinical Trial Collaboration
AUBURNDALE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Advantagene, Inc. today announced that the company entered into a clinical trial collaboration with Bristol-Myers Squibb (NYSE:BMY) to . . .
Posted on 4/27/18
Spring Bank Pharmaceuticals Provides Corporate Update
HOPKINTON, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, . . .
Posted on 4/27/18
Managed Care Pharmacy Leaders Are Honored at the Academy of Managed Care Pharmacy/AMCP Foundation Awards Dinner
The Academy of Managed Care Pharmacy and AMCP Foundation last night recognized a group of leaders who have contributed significantly to the profession of managed care . . .
Posted on 4/26/18
Halifax-Backed Delphi Behavioral Health Group Merges With Summit Behavioral Health
Delphi Behavioral Health Group, a leading substance abuse treatment provider, announced today it has merged with Summit Behavioral Health to expand its service
Posted on 4/27/18
PAREXEL Appoints Peyton Howell as Chief Commercial and Strategy Officer
PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today announced the appointment of Peyton Howell as Chief Commercial
Posted on 4/26/18
Biogen Q1 2018: Too Cheap To Ignore
On January 2018, I suggested to be cautious on Biogen (NASDAQ:BIIB), and I was right with the stock underperforming by 30% over the last three months.Despite . . .
Posted on 4/25/18
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50M Public Offering of Common Stock
WALTHAM, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (Nasdaq:ELOX) today announced the pricing of an underwritten public offering of 5,130,000 shares of its common . . .
Posted on 4/25/18
SimplyVital Health and LifeStory Health Announce New Partnership
SimplyVital Health (SVH), the transformational blockchain healthcare company, has announced a new partnership with LifeStory Health (LSH), which is developing novel diagnostics and potential therapeutic targets . . .
Posted on 4/25/18
Applied BioMath Announces Collaboration with Sanofi
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced a collaboration with Sanofi for the analysis of systems pharmacology . . .
Posted on 4/25/18
Fresenius Medical Care North America Launches Corporate Charitable Foundation
Fresenius Medical Care North America (FMCNA), the leading provider of kidney care products and services, today announced the launch of the Fresenius Medical Care Foundation, a . . .
Posted on 4/25/18
Concert Pharmaceuticals Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata
Topline Phase 2a Data from the 4 mg and 8 mg Cohorts Expected in Fourth Quarter of 2018Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it . . .
Posted on 4/25/18
Biogen's (BIIB) CEO Michel Vounatsos on Q1 2018 Results - Earnings Call Transcript
Biogen, Inc. (NASDAQ:BIIB) Q1 2018 Earnings Conference Call April 24, 2018 8:30 AM ETExecutivesMatt Calistri - VP, IRMichel Vounatsos - CEOMichael Ehlers - EVP, Research & . . .
Posted on 4/24/18
Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTCQB:ELOX) today announced that it intends to offer and sell, subject to market and other conditions, . . .
Posted on 4/24/18
Lysogene Signs Partnership Agreement with Dr. Hervé Moine
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Lysogene (Paris:LYS) (FR0013233475 – LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central nervous system (CNS) diseases, announces the . . .
Posted on 4/24/18
Compass Health Systems Selects Meridian Medical Management for Robotic Automation
WINDSOR, Conn., April 24, 2018 (GLOBE NEWSWIRE) -- Meridian Medical Management today announced that Compass Health Systems, a behavioral and medical services organization, has selected Meridian . . .
Posted on 4/24/18
Why Is Biogen Inc. Giving Ionis Another $1 Billion?
The first commercialized product to emerge from Biogen Inc.'s (NASDAQ:BIIB) collaboration deal with Ionis Pharmaceuticals Inc. (NASDAQ:IONS) is an out-of-the-park home run. Building on an already . . .

